U.S. Markets closed

Weekly CFO Buys Highlight

According to GuruFocus Insider Data, the recent chief financial officer buys were Mayville Engineering Co. Inc. (NYSE:MEC), Verb Technology Co Inc. (NASDAQ:VERB) and TFF Pharmaceuticals Inc. (NASDAQ:TFFP).

Mayville Engineering CFO bought 10,000 shares

CFO Todd M. Butz bought 10,000 shares for $8.75 per share on Oct. 30. Since then, the stock has gained 15.89%. Mayville Engineering has a market cap of $200.17 million and its shares were traded around $10.14. The company has a price-earnings ratio of 18.78 and a price-sales ratio of 0.59.


Mayville Engineering announced its second-quarter results with revenue of $145.13 million and gross profit of $20.54 million, while the net loss was $15.28 million. The 2018 total revenue was $354.53 million, a 13% increase from 2017. The gross profit was $50.58 million, a 46% increase from the year prior. The net loss was $17.94 million.

Chairman, President and CEO Robert D. Kamphuis bought 20,000 shares for $8.79 per share on Oct. 30. Since then, the share price has increased by 15.36%.

Director Timothy L. Christen bought 12,500 shares for $8.94 per share on Oct. 30. Since then, the stock has increased 13.42%.

Verb Technology CFO bought 1,500 shares

CFO Jeff Clayborne bought 1,500 shares for $1.05 per share on Oct. 22. Since then, the share price has decreased by 1.9%. Verb Technology has a market cap of $23.960 million and its shares were traded around $1.03. The company has a price-sales ratio of 5.84.

Verb Technology announced its second-quarter results with revenue of $3.73 million and gross profit of $1.69 million, while the net loss was $2.34 million. The 2018 total revenue was $32,000, a 433% increase from 2017, while the 2018 gross loss was $20,000. The 2018 net loss was $12.13 million.

CEO Rory J. Cutaia bought 1,500 shares for $1.17 per share on Oct. 4. Since then, the stock has declined 11.97%. Director Kenneth S. Cragun bought 1,500 shares for $1.01 per share on Oct. 29. Since then, the stock price has increased by 1.98%. Director Phillip J. Bond bought 1,500 shares for $1.06 per share on Oct. 17. Since then, the stock price has decreased by 2.83%.

TFF Pharmaceuticals CFO bought 1,000 shares

CFO, Secretary and Treasurer Kirk Allen Coleman bought 1,000 shares for $5 per share on Oct. 25. Since then, the stock price has increased by 1%. TFF Pharmaceuticals has a market cap of $90.020 million and its shares were traded around $5.05.

President and CEO Glenn R. Mattes bought 10,000 shares for $5 per share on Oct. 25. Since then, the stock price has increased by 1%. Chief Science Officer James Brian Windsor bought 5,000 shares for $5 per share on Oct. 25. Since then, the stock price has increased by 1%. Director Harlan F. Weisman bought 5,000 shares for $5 per share on Oct. 25. Since then, the stock price has increased by 1%.

Disclosure: None.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.